LL
LIVE

Serial Number

79437471

Owner

Leyden Laboratories B.V.

Attorney

Stacy J. Grossman

Filing Date

Aug 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LL Trademark

Serial Number: 79437471

LL is a trademark filed by Leyden Laboratories B.V. on August 19, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Leyden Laboratories B.V. (8 trademarks)

Emmy Noetherweg 2

Entity Type: 26

Trademark Details

Filing Date

August 19, 2025

Registration Date

Not Registered

Goods & Services

Wholesale store services in the field of pharmaceutical products for the treatment of viral diseases, virucides, vaccines, vaccine adjuvants, viral vaccines, also provided online

Medical and pharmaceutical advice.

Pharmaceutical products for the treatment of viral diseases; virucides; vaccines; vaccine adjuvants; viral vaccines.

Research and development in the field of pharmaceutical products for the treatment of viral diseases, virucides, vaccines, vaccine adjuvants, viral vaccines.

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 16, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jul 16, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jul 16, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 16, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 19, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 4, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 4, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 20, 2025 REPR